Cochrane has published several reviews of the effects of interventions to reduce self-harm and suicide and, in the first few months of 2021, three of these were updated covering pharmacological and psychosocial interventions for self-harm in children, adolescents and adults. We asked two of the authors, Keith Hawton and Katrina Witt to tell us about the findings in this podcast.

Note: This recording covers three reviews:
- Interventions for children and adolescents who self-harm
- Psychosocial interventions for adults who self-harm
- Drugs and natural products for self-harm in adults

Cochrane has published several reviews of the effects of interventions to reduce self-harm and suicide and, in the first few months of 2021, three of these were updated covering pharmacological and psychosocial interventions for self-harm in children, adolescents and adults. We asked two of the authors, Keith Hawton and Katrina Witt to tell us about the findings in this podcast.

Note: This recording actually covers three reviews:
- Interventions for children and adolescents who self-harm
- Psychosocial interventions for adults who self-harm
- Drugs and natural products for self-harm in adults

Cochrane is preparing a series of reviews to help decision makers deal with the COVID-19 pandemic and its impact. We are keeping these up to date as new evidence becomes available and the review of using signs and symptoms to diagnose whether someone has the disease has been updated for the second time. The review was first published in June 2020 and the most recent update was published in May 2022. Here's the lead author, Thomas Struyf from the Katholieke Universiteit Leuven in Belgium, to tell us about the latest findings.

There are now more than two dozen Cochrane reviews of high priority topics relevant to COVID-19, which are being kept up to date as new evidence becomes available. In March 2022, we published updated findings on the effects of anticoagulants and we asked lead author, Ronald Flumignan from the Federal University of Sao Paulo in Brazil to summarize the evidence in this podcast.

Cochrane is producing a growing series of reviews on the care of patients with COVID-19. In January 2022, we published a new review of a group of treatments called interleukin-1 blocking agents and we asked lead author, Mauricia Davidson from Cochrane France, to tell us about the findings.

The Cochrane Neonatal Group has produced more than 400 reviews over the last two decades and, in February 2022, they published their overview of reviews of treatments for rapid breathing in babies. We asked two of the co-authors, Olga Romantsik and Matteo Bruschettini from Skåne University Hospital in Lund, Sweden, to tell us about the latest findings.

Every year, approximately 14 million around the world have a stroke, and the Cochrane Stroke Group has produced more than 200 reviews in the last 25 years. In November 2021, they updated the review of information provision for stroke survivors and their carers, and two of the authors, Tom Crocker and Lesley Brown from the Bradford Teaching Hospitals NHS Foundation Trust in the UK discuss the latest findings in this podcast.

The Cochrane Gynaecology and Fertility Group had produced approximately 100 reviews relevant to in vitro fertilisation, or IVF and updates these in light of new evidence. The second update of their review of a technique called endometrial scratching was published in June 2021 and, in this podcast, Dr Rob Axe speaks with one of the authors Dr Sarah Armstrong, from the University of Sheffield in the UK about the technique and their latest findings on its effects.

Some new-born babies will suffer from jaundice and there are several Cochrane reviews of possible ways to prevent or treat it. These were added to in July 2021 with a new review of the effects of sunlight. We asked the review's lead author, Delia Horn from the Larner College of Medicine at the University of Vermont in the USA, to tell us about the importance of this topic and the findings of the review.

Over the last year, Cochrane Neuro-Oncology have been publishing a series of new systematic reviews on priority topics for the brain tumour community. These were selected from the most important unanswered questions identified by patients, the public and practitioners. In this podcast, Kathreena Kurian from the University of Bristol in the UK tells us about one of the reviews, which was published in March 2022, looking at the evidence on some of the tests that might help in planning the treatment of patients with a glioma.